Vanda Pharmaceuticals Inc Capital Reinvestment Ratio
Vanda Pharmaceuticals Inc capital reinvestment ratio. Vanda Pharmaceuticals Inc (VNDA) has a Capital Reinvestment Ratio of 0.00x as of March 2024, meaning it reinvests 0% of its operating cash flow ($7.57 Million) in capital expenditures ($7.00K). Check VNDA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Vanda Pharmaceuticals Inc (2009–2023)
Capital reinvestment ratio of Vanda Pharmaceuticals Inc from 2009 to 2023. This chart tracks Vanda Pharmaceuticals Inc's Capital Reinvestment Ratio across 8 annual periods. Also explore VNDA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Vanda Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2009–2023)
Vanda Pharmaceuticals Inc capital reinvestment ratio by year from 2009 to 2023. For the full cash flow conversion analysis, see cash flow conversion of Vanda Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.03x | $12.80 Million | $383.00K | ▲ +40.9% |
| 2022 | 0.02x | $31.98 Million | $679.00K | ▲ +147.0% |
| 2021 | 0.01x | $64.21 Million | $552.00K | ▼ -75.2% |
| 2020 | 0.03x | $51.77 Million | $1.79 Million | ▲ +56.3% |
| 2019 | 0.02x | $45.95 Million | $1.02 Million | ▼ -97.4% |
| 2018 | 0.85x | $29.99 Million | $25.37 Million | ▲ +316.8% |
| 2015 | 0.20x | $12.45 Million | $2.53 Million | ▲ +186.4% |
| 2009 | 0.07x | $169.34 Million | $12.00 Million | — |